Sativex and Multiple Sclerosis

Sativex and Multiple Sclerosis

Mar. 1, 2011
European Journal of Neurology

Alena Novotna, MD, et al., stated the following in their Mar. 1, 2011 study titled “A Randomized, Double-blind, Placebo-controlled, Parallel-group, Enriched-design Study of Nabiximols (Sativex), as Add-on Therapy, in Subjects with Refractory Spasticity Caused by Multiple Sclerosis,” published in the European Journal of Neurology:“Spasticity is a disabling complication of multiple sclerosis, affecting many patients with the condition. Subjects were treated with nabiximols [Sativex],as add-on therapy, in a single-blind manner… This study has shown Sativex to improve spasticity in patients who had failed to respond adequately to other antispasticity medications…”

Author: Mike

Share This Post On

Submit a Comment